Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA07010824 Cyclohexyl butanoate cyclohexyl butanoate WE 10:1 C10H18O2 170.130680
LMFA07010824 Cyclohexyl butanoate cyclohexyl butanoate WE 10:1 C10H18O2 170.130680
LMFA08020162 (E,E)-2,4-Decadienoic isobutylamide (2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide NA 14:2 C14H25NO 223.193614
LMFA08020162 (E,E)-2,4-Decadienoic isobutylamide (2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide NA 14:2 C14H25NO 223.193614
LMFA08020162 (E,E)-2,4-Decadienoic isobutylamide (2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide NA 14:2 C14H25NO 223.193614
LMFA07010842 Dodecyl 2-methylpropanoate dodecyl 2-methylpropanoate WE 16:0 C16H32O2 256.240231
LMFA07010842 Dodecyl 2-methylpropanoate dodecyl 2-methylpropanoate WE 16:0 C16H32O2 256.240231
LMFA07010438 hexyl hexanoate hexyl hexanoate WE 12:0 C12H24O2 200.177630
LMFA07070065 Glutaconylcarnitine (3S)-3-{[(2E)-4-carboxybut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 5:2;O2 C12H19NO6 273.121239
LMFA07070065 Glutaconylcarnitine (3S)-3-{[(2E)-4-carboxybut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 5:2;O2 C12H19NO6 273.121239
LMFA07070094 O-methylmalonylcarnitine 3-[(2-carboxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 4:1;O2 C11H19NO6 261.121239
LMFA07070094 O-methylmalonylcarnitine 3-[(2-carboxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 4:1;O2 C11H19NO6 261.121239
LMFA07050219 3-hydroxyisoheptadecanoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-15-methylhexadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 17:0;O C38H68N7O18P3S 1035.355440
LMFA07050219 3-hydroxyisoheptadecanoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-15-methylhexadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 17:0;O C38H68N7O18P3S 1035.355440
LMFA07050219 3-hydroxyisoheptadecanoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-15-methylhexadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 17:0;O C38H68N7O18P3S 1035.355440
LMFA07050219 3-hydroxyisoheptadecanoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-15-methylhexadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 17:0;O C38H68N7O18P3S 1035.355440
LMFA07050219 3-hydroxyisoheptadecanoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-15-methylhexadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 17:0;O C38H68N7O18P3S 1035.355440
LMFA07050219 3-hydroxyisoheptadecanoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-15-methylhexadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 17:0;O C38H68N7O18P3S 1035.355440
LMFA07050348 Malyl-CoA (2S)-4-{[2-(3-{3-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido}propanamido)ethyl]sulfanyl}-2-hydroxy-4-oxobutanoic acid CoA 4:1;O3 C25H40N7O20P3S 883.126169
LMFA07050348 Malyl-CoA (2S)-4-{[2-(3-{3-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido}propanamido)ethyl]sulfanyl}-2-hydroxy-4-oxobutanoic acid CoA 4:1;O3 C25H40N7O20P3S 883.126169
LMFA07050348 Malyl-CoA (2S)-4-{[2-(3-{3-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido}propanamido)ethyl]sulfanyl}-2-hydroxy-4-oxobutanoic acid CoA 4:1;O3 C25H40N7O20P3S 883.126169
LMFA07050348 Malyl-CoA (2S)-4-{[2-(3-{3-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido}propanamido)ethyl]sulfanyl}-2-hydroxy-4-oxobutanoic acid CoA 4:1;O3 C25H40N7O20P3S 883.126169
LMFA07050348 Malyl-CoA (2S)-4-{[2-(3-{3-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido}propanamido)ethyl]sulfanyl}-2-hydroxy-4-oxobutanoic acid CoA 4:1;O3 C25H40N7O20P3S 883.126169
LMFA07050348 Malyl-CoA (2S)-4-{[2-(3-{3-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido}propanamido)ethyl]sulfanyl}-2-hydroxy-4-oxobutanoic acid CoA 4:1;O3 C25H40N7O20P3S 883.126169
LMFA07010919 Isopentyl isopentanoate 3-methylbutyl 3-methylbutanoate WE 10:0 C10H20O2 172.146330
LMFA07010919 Isopentyl isopentanoate 3-methylbutyl 3-methylbutanoate WE 10:0 C10H20O2 172.146330
LMFA07010977 Nonyl isovalerate nonyl 3-methylbutanoate WE 14:0 C14H28O2 228.208930
LMFA07010977 Nonyl isovalerate nonyl 3-methylbutanoate WE 14:0 C14H28O2 228.208930
LMFA07070109 trans-Hexadec-2-enoyl carnitine 3-[(2E)-hexadec-2-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:1 C23H43NO4 397.319209
LMFA07070109 trans-Hexadec-2-enoyl carnitine 3-[(2E)-hexadec-2-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:1 C23H43NO4 397.319209
LMFA07010797 Butyl undecylenate butyl undec-10-enoate SFE 15:1 C15H28O2 240.208930
LMFA07010797 Butyl undecylenate butyl undec-10-enoate SFE 15:1 C15H28O2 240.208930
LMFA07010915 Isobutyl 2-furanpropionate 2-methylpropyl 3-(furan-2-yl)propanoate WE 11:3;O C11H16O3 196.109945
LMFA07010915 Isobutyl 2-furanpropionate 2-methylpropyl 3-(furan-2-yl)propanoate WE 11:3;O C11H16O3 196.109945
LMFA07010915 Isobutyl 2-furanpropionate 2-methylpropyl 3-(furan-2-yl)propanoate WE 11:3;O C11H16O3 196.109945
LMFA04020251 (4R,8S,11R)-d5-7-NeuroF[7R,10S] (R,E)-4-hydroxy-6-((2R,3S,5S)-3-hydroxy-5-((R,3Z,6Z,9Z)-1-hydroxydodeca-3,6,9-trien-1-yl)tetrahydrofuran-2-yl)hex-5-enoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA06000001 Enanthaldehyde heptanal FAL 7:0 C7H14O 114.104465
LMFA07010862 Ethyl 3-cyclohexylpropionate ethyl 3-cyclohexylpropanoate SFE 11:1 C11H20O2 184.146330
LMFA07010862 Ethyl 3-cyclohexylpropionate ethyl 3-cyclohexylpropanoate SFE 11:1 C11H20O2 184.146330
LMFA07010855 Ethyl 2-ethylhexanoate ethyl 2-ethylhexanoate SFE 10:0 C10H20O2 172.146330
LMFA07010855 Ethyl 2-ethylhexanoate ethyl 2-ethylhexanoate SFE 10:0 C10H20O2 172.146330
LMFA04020409 (8R,11S,14R)-d12-7-NeuroF[7S,10S] (Z)-6-((2S,3R,5S)-5-((1S,2E,4R,6Z,9Z)-1,4-dihydroxydodeca-2,6,9-trien-1-yl)-3-hydroxytetrahydrofuran-2-yl)hex-4-enoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA07050382 trans-2-Enoyl-OPC8-CoA CoA 18:4;O C39H62N7O18P3S 1041.308490
LMFA07050382 trans-2-Enoyl-OPC8-CoA CoA 18:4;O C39H62N7O18P3S 1041.308490
LMFA07050382 trans-2-Enoyl-OPC8-CoA CoA 18:4;O C39H62N7O18P3S 1041.308490
LMFA07050382 trans-2-Enoyl-OPC8-CoA CoA 18:4;O C39H62N7O18P3S 1041.308490
LMFA07050382 trans-2-Enoyl-OPC8-CoA CoA 18:4;O C39H62N7O18P3S 1041.308490
LMFA07050382 trans-2-Enoyl-OPC8-CoA CoA 18:4;O C39H62N7O18P3S 1041.308490
LMFA04020351 (11R,14S,17S)-d15-10-NeuroF[10R,13S] (4Z,7Z)-9-((2R,3R,5S)-5-((1S,2E,4S,6Z)-1,4-dihydroxynona-2,6-dien-1-yl)-3-hydroxytetrahydrofuran-2-yl)nona-4,7-dienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA04020292 (14S,17R,20R)-d18-13-NeuroF[13R,16R] (4Z,7Z,10Z)-12-((2R,3S,5R)-5-((1R,4R,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)dodeca-4,7,10-trienoic acid FA 22:5;O4 C22H34O6 394.235541